Floatz logo

Golidocitinib

Enteropathy Associated T Cell Lymphoma

Ruijin HospitalSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

20 Active assets in the Enteropathy Associated T Cell Lymphoma cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Eric Jacobsen, MD
Phase 4BBB
Inno-206
Eric Jacobsen, MD
Phase 4BBB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 4BBB
Ifosfamide
Shandong Provincial Hospital
Phase 4BB
PREDNISONE TABLETS
Eric Jacobsen, MD
Phase 4BB

View all 36 →

Same molecule, other indications

Golidocitinib is also rated in:

non-small cell lung carcinomaDormant
BB
Indicative ·
68 / 100
View asset →
peripheral T-cell lymphoma, not otherwise specifiedDormant
B
Indicative ·
63 / 100
View asset →
extranodal nasal NK/T cell lymphomaDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →